About the 3e Initiative in Rheumatology
The aim of the 3e (evidence, expertise and exchange) initiative is a multi-national effort to develop recommendations for the management of musculoskeletal disorders.
Unlike guidelines or recommendations developed by a limited panel of experts in the field, the 3e initiative involved a large number of experts, combined with practicing rheumatologists, who addressed specific and detailed questions relevant to every-day clinical practice.
While the current 3e initiative focuses on undifferentiated peripheral inflammatory arthritis (UPIA) initiative, previous initiatives focused on the investigation and follow-up of ankylosing spondylitis and methotrexate in rheumatic disorders.
The 3e Methodology was a comprehensive, evidence-based process. To learn more click here.
The 3e program integrated input from global participants that included representatives from: Australia – New Zealand, Austria, Belgium – Luxembourg, Brazil, Canada, Colombia, Denmark, Germany, Ireland, Italy, Mexico, Netherlands, Norway, Portugal, Spain, United Kingdom, Venezuela.
A Multi-national Effort – Scientific Committees:
Mouse over a participant country icon to display individuals from that nation who were involved in establishing the 2008-2009 3e Recommendations for UPIA.
To view a full listing of all UPIA Scientific Committee Members, click here.